(Q45934408)

18 December 2017

title

Trends in the utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer: results from the National Cancer Database. (English)

1 reference

18 December 2017

1 reference

1 reference

7

Sam S Chang

1 reference

18 December 2017

author name string

Harras B Zaid

1

1 reference

18 December 2017

Sanjay G Patel

2

1 reference

18 December 2017

C J Stimson

3

1 reference

18 December 2017

Matthew J Resnick

4

1 reference

18 December 2017

Michael S Cookson

5

1 reference

18 December 2017

Daniel A Barocas

6

1 reference

18 December 2017

language of work or name

English

0 references

publication date

11 November 2013

1 reference

18 December 2017

published in

Urology

1 reference

18 December 2017

volume

83

1 reference

18 December 2017

page(s)

75-80

1 reference

18 December 2017

issue

1

1 reference

18 December 2017

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.072

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.072

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.072

Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.072

International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.072

Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.072

The National Cancer Data Base: a powerful initiative to improve cancer care in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.072

Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.072

Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.072

Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.072

Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.072

The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.072

Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.072

10.1016/J.UROLOGY.2013.07.072

7 January 2021

Identifiers

DOI

1 reference

18 December 2017

PubMed ID

24231210

1 reference

18 December 2017